Conditions: Healthy
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 30
Healthy volunteers: yes

Brief summary:
The objective of the current trial is to establish the bioequivalence of 2 hyoscine butylbromide dose forms following oral administration.

Detailed description:

Arms:
arm 1: drops, oral administration with 240 mL water arm 2: sugar coated tablets, oral administration with 240 mL water

Interventions: intervention 1: Hyoscine butylbromide intervention 2: Hyoscine butylbromide
Intervention descriptions: intervention 1: sugar coated tablets for oral administration intervention 2: drops for oral administration

Protocol document: